| Date | Name | Shares | Transaction | Value |
|
Feb 13, 2026
| John Hazlin Chief Growth Officer |
38,634
| Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 Non-derivative transaction at $76.41 per share |
2,952,023.94
|
|
Feb 13, 2026
| John Hazlin Chief Growth Officer |
17,645
| Open market or private sale of non-derivative or derivative security Non-derivative transaction at $94.25 per share |
1,663,041.25
|
|
Feb 13, 2026
| John Hazlin Chief Growth Officer |
N/A
| Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 |
0.00
|
|
May 20, 2025
| Sally Massey Chief Human Resources Officer |
12,583
| Open market or private sale of non-derivative or derivative security Non-derivative transaction at $88.97 per share |
1,119,509.51
|
|
Apr 4, 2025
| John P. Bilbrey Director |
33,688
| Grant, award or other acq pursuant to Rule 16b-3(d) Non-derivative transaction at $91.99 per share |
3,098,959.12
|
|
Apr 4, 2025
| Lorrie M. Norrington Director |
36,002
| Grant, award or other acq pursuant to Rule 16b-3(d) Non-derivative transaction at $91.99 per share |
3,311,823.98
|
|
Apr 4, 2025
| Brian O. Newman Director |
2,597
| Grant, award or other acq pursuant to Rule 16b-3(d) Non-derivative transaction at $91.99 per share |
238,898.03
|